Great Point Partners LLC Context Therapeutics Inc. Transaction History
Great Point Partners LLC
- $162 Million
- Q1 2025
A detailed history of Great Point Partners LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 4,683,711 shares of CNTX stock, worth $3 Million. This represents 1.77% of its overall portfolio holdings.
Number of Shares
4,683,711
Previous 4,683,711
-0.0%
Holding current value
$3 Million
Previous $4.64 Million
38.37%
% of portfolio
1.77%
Previous 3.06%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
47Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$9.41 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$4.79 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$4.75 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$4.75 Million1.06% of portfolio
-
Nextech Invest Ag7.42MShares$4.75 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.2M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...